GLS

Glenmark Life Sciences Share PriceGlenmark Life Sciences

₹547.85
4.95 (0.91%)
As on 03 June, 2023 | 16:49 BSE: 543322 NSE: GLS

Glenmark Life Sciences Performance

Day Range

  • Low
  • High
547.85

52 Week Range

  • Low
  • High
547.85
  • Open Price
  • Previous Close
  • Volume

Start SIP in Glenmark Life Sciences

Start SIP

Glenmark Life Sciences Share Price

  • Over 1 Month 5.73%
  • Over 3 Month 44%
  • Over 6 Month 26.66%
  • Over 1 Year 28.26%

Glenmark Life Sciences Key Statistics

P/E Ratio 14.4
PEG Ratio 1.2
Market Cap Cr 6,713
Price to Book Ratio 3.1
EPS 38.1
Dividend 5.7
Relative Strength Index 64.56
Money Flow Index 47.89
MACD Signal 21.02
Average True Range 18.16

Glenmark Life Sciences Investment Rating

  • Master Rating:
  • Glenmark Life Sciences has an operating revenue of Rs. 2,161.22 Cr. on a trailing 12-month basis. An annual revenue growth of 2% is not great, Pre-tax margin of 29% is great, ROE of 21% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is comfortably placed above its key moving averages, around 15% and 28% from 50DMA and 200DMA. It has recently broken out of a base in its weekly chart and is trading around 20% from the pivot point (which is extended from the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 90 which is a GREAT score indicating consistency in earnings, a RS Rating of 80 which is GOOD indicating the outperformance as compared to other stocks, Buyer Demand at A+ which is evident from recent demand for the stock, Group Rank of 24 indicates it belongs to a strong industry group of Medical-Ethical Drugs and a Master Score of B is close to being the best. Overall, the stock has great fundamentals and technical strength to stay in momentum.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Glenmark Life Sciences Financials
IndicatorMar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 621541509490514
Operating Expenses Qtr Cr 415395366343372
Operating Profit Qtr Cr 206145144147142
Depreciation Qtr Cr 1211101010
Interest Qtr Cr 00000
Tax Qtr Cr 5136373839
Net Profit Qtr Cr 14610510710999

Glenmark Life Sciences Technicals

EMA & SMA

Current Price
₹547.85
4.95 (0.91%)
  • Bullish Moving Average
  • ___
  • 16
  • Bearish Moving Average
  • ___
  • 0
  • 20 Day
  • ₹527.26
  • 50 Day
  • ₹488.59
  • 100 Day
  • ₹458.06
  • 200 Day
  • ₹452.39
  • 20 Day
  • ₹534.06
  • 50 Day
  • ₹474.79
  • 100 Day
  • ₹432.28
  • 200 Day
  • ₹427.28

Glenmark Life Sciences Resistance and Support

PIVOT
₹542.04
Resistance
First Resistance ₹548.02
Second Resistance ₹553.14
Third Resistance ₹559.12
RSI 64.56
MFI 47.89
MACD Single Line 21.02
MACD 18.43
Support
First Resistance ₹536.92
Second Resistance ₹530.94
Third Resistance ₹525.82

Glenmark Life Sciences Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 149,432 7,060,662 47.25
Week 150,838 8,362,459 55.44
1 Month 254,162 15,148,077 59.6
6 Month 161,628 10,041,954 62.13

Glenmark Life Sciences Result Highlights

Glenmark Life Sciences Synopsis

NSE-Medical-Ethical Drugs

Glenmark Life Scienc belongs to the Industry of Pharmaceuticals. Company’s Total Operating Revenue is Rs. 2161.22 Cr. and Equity Capital is Rs. 24.51 Cr. for the Year ended 31/03/2023. Glenmark Life Sciences Ltd. is a Public Limited Listed company incorporated on 23/06/2011 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L74900PN2011PLC139963 and registration number is 139963.
Market Cap 6,713
Sales 2,161
Shares in Float 2.08
No of funds 20
Yield 5.75
Book Value 3.14
U/D Vol ratio 1.7
LTDebt / Equity
Alpha 0.08
Beta 0.51

Glenmark Life Sciences

Owner NameMar-23Dec-22Sep-22Jun-22
Promoters 82.85%82.85%82.85%82.85%
Mutual Funds 0.71%0.71%
Insurance Companies 0.07%0.07%
Foreign Portfolio Investors 3.28%4.45%6.04%7.58%
Financial Institutions/ Banks
Individual Investors 10.87%9.78%9.14%8.14%
Others 3%2.85%1.19%0.72%

Glenmark Life Sciences Management

Name Designation
Mr. Glenn Saldanha Chairman & Non-Exe.Director
Mr. Yasir Rawjee Managing Director & CEO
Mr. Sumantra Mitra Executive Director
Mr. V S Mani Non Executive Director
Mr. Sridhar Gorthi Independent Director
Mrs. Manju Agarwal Independent Director
Mr. Taruvai Laxminarayanan Easwar Independent Director
Ms. Gita Nayyar Independent Director

Glenmark Life Sciences Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Glenmark Life Sciences Corporate Action

Date Purpose Remarks
2023-04-27 Audited Results
2023-03-16 Interim Dividend
2023-01-27 Quarterly Results
2022-10-21 Quarterly Results
2022-08-04 Quarterly Results
Date Purpose Remarks
2023-03-24 INTERIM Rs.21.00 per share(1050%)Interim Dividend
2021-11-23 INTERIM Rs.10.50 per share(525%)Interim Dividend

Glenmark Life Sciences MF Shareholding

Name Amount(cr)
Motilal Oswal S&P BSE Healthcare ETF 6

Glenmark Life Sciences FAQs

What is Share Price of Glenmark Life Sciences ?

Glenmark Life Sciences share price is ₹547 As on 03 June, 2023 | 16:35

What is the Market Cap of Glenmark Life Sciences ?

The Market Cap of Glenmark Life Sciences is ₹6712.7 Cr As on 03 June, 2023 | 16:35

What is the P/E ratio of Glenmark Life Sciences ?

The P/E ratio of Glenmark Life Sciences is 14.4 As on 03 June, 2023 | 16:35

What is the PB ratio of Glenmark Life Sciences ?

The PB ratio of Glenmark Life Sciences is 3.1 As on 03 June, 2023 | 16:35

Q2FY23

Start Investing Now!

Open Free Demat Account in 5 mins

Enter Valid Mobile Number